ACAVSDNA• 28 Days (Normalized)
ACA vs DNA (Arcosa Inc. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACA Performance $147.18
+1.5%
Arcosa Inc.
Normalized Baseline0.00%
DNA Performance $13
+92.59%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-91.09 pts
DNA outperforming by 91.09 percentage points
ACADNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACA DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | ACA Price | ACA Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $147.18 | +1.50% | $13.00 | +92.59% | -91.09% |
| Oct 08, 2026 | $146.50 | +1.03% | $11.34 | +68.00% | -66.97% |
| Oct 07, 2026 | $146.40 | +0.97% | $11.47 | +69.93% | -68.96% |
| Oct 06, 2026 | $146.50 | +1.03% | $12.41 | +83.85% | -82.82% |
| Oct 05, 2026 | $146.75 | +1.21% | $14.98 | +121.93% | -120.72% |
| Oct 02, 2026 | $146.50 | +1.03% | $12.35 | +82.96% | -81.93% |
| Oct 01, 2026 | $146.50 | +1.03% | $12.50 | +85.19% | -84.16% |
| Sep 30, 2026 | $146.15 | +0.79% | $12.83 | +90.07% | -89.28% |
| Sep 29, 2026 | $146.00 | +0.69% | $11.96 | +77.19% | -76.50% |
| Sep 28, 2026 | $146.53 | +1.06% | $10.46 | +54.96% | -53.90% |
| Sep 25, 2026 | $146.62 | +1.12% | $10.66 | +57.93% | -56.81% |
| Sep 24, 2026 | $- | $10.25 | +51.85% | - | |
| Sep 23, 2026 | $146.50 | +1.03% | $8.58 | +27.11% | -26.08% |
| Sep 22, 2026 | $146.60 | +1.10% | $9.37 | +38.81% | -37.71% |
| Sep 21, 2026 | $146.22 | +0.84% | $7.98 | +18.22% | -17.38% |
Page 1 of 2